Tamoxifen does not correct the underlying metabolic imbalance, it has never worked

Our Government and the FDA passed the regulation four years ago telling the makers of Tamoxifen they could not claim that it prevented cancer. So they cannot do that, but they can buy doctors and have them claim it. A little escape hole in the law. Isn't that amazing? So doctors go around thinking, "Gee someone over at Cincinnati says we should continue to use Tamoxifen."

Now Tamoxifen is blocked in the breast, but it is oestrogenic in the uterus and it causes cancer of the uterus. Now normally cancer of the uterus is a very benign disease. It shows up as a little bleeding here and there. And you find it, you do a pap smear and you see abnormal cells and you remove the uterus and it has gone, OK.

If you get cancer of the uterus when you are on Tamoxifen it is a different ball game instead of zero deaths there is 87% of you will die. It is a very rapid untreatable malignancy if it is caused by Tamoxifen. Tamoxifen also increases your risk of strokes and blindness and it does no good. There is no test that shows that it works. And yet that is what the doctor gives you because he knows that your own oestrogen is going to cause the breast cancer in the other breast. Or he might recommend let us remove the other breast right now. Then you won't get it, and women are buying that. Instead of saying let us find what is causing this and we can correct the underlying metabolic imbalance and then it won't happen.

A prime example of corporate control is the annual October Breast Cancer Awareness Month (BCAM). According to "BCAM SCAM," an expose published in The Nation, the BCAM idea "was conceived and paid for by a British chemical company that both profits from this epidemic and may be contributing to its cause. Imperial Chemical Industries (ICI) along with two non-profit groups, co-founded BCAM nine years ago. The October event has grown in influence with thirteen institutions now on its board which include the American Cancer Society and the National Cancer Institute. BCAM has become fashionable too: Avon, Estee Lauder and Hanes have lent sponsorship. But, since the beginning, all BCAM's bills have been paid by Zeneca Pharmaceuticals, the new name of ICI's U.S. subsidiary. Altogether, ICI has spent several million dollars on BCAM, according to [a] Zeneca spokeswoman."

For this support, ICI can control the message: "Early detection is your best protection."

Janet Collins thinks the better message is "Prevention is your best protection." We have no trouble accepting immunization for our children and thus have decreased suffering and death from polio, whooping cough, tetanus, diphtheria and the like. Why do we accept less than true prevention when it comes to cancer? Janet also says "this practice of polluting corporations recruiting women as their spokespeople drives me crazy. Not only do they get to give the impression that they are equal opportunity and that women are with them side-by-side in the march of progress, but the cowards get to hide behind the skirts of women." Early detection is important, because like other cancers, breast cancer is more curable before it has spread. But, detection is not prevention: ICI is in the business of manufacturing and selling synthetic chemicals. With annual sales well in excess of $18 billion, ICI is one of the world's largest producers and users of chlorine.

And, as discussed earlier, ICI/Zeneca manufactures tamoxifen, (brand name is NOLVADEX) the world's top-selling cancer drug used for breast cancer. Breast cancer activists must understand that what is good for a corporate sponsor may not be in the interest of the activist.